48,833
edits
(+URL) |
|||
Line 117: | Line 117: | ||
</pre> | </pre> | ||
The above exactly mirrors the Canadian consensus.<ref name=driman>{{cite journal | last1 = Driman | first1 = DK. | last2 = Marcus | first2 = VA. | last3 = Hilsden | first3 = RJ | last4 = Owen | first4 = DA |title=Pathologic reporting of colorectal polyps: pan-Canadian consensus guidelines |journal=Canadian Journal of Pathology |volume=4 |issue=3 |pages=81-90 |year=2012 |month= |pmid= |doi= |url=http://andrewjohnpublishing.com/images/cjp%204-3.pdf }}</ref> | |||
====Management==== | |||
The Canadian Partnership Against Cancer (2011) advocates the following statement:<ref>URL: [http://www.cancercare.ns.ca/site-cc/media/cancercare/Pathology%20Working%20Group_Phase%201%20Report_Final_Nov%202011_For%20Email.pdf http://www.cancercare.ns.ca/site-cc/media/cancercare/Pathology%20Working%20Group_Phase%201%20Report_Final_Nov%202011_For%20Email.pdf]. Accessed on: January 29, 2015.</ref> | |||
<pre> | |||
Sessile serrated adenomas with dysplasia are considered to be advanced lesions that | |||
have an increased propensity to transform to adenocarcinoma. Complete endoscopic removal | |||
is recommended. If complete endoscopic removal cannot be achieved, short-term re-endoscopy | |||
and biopsy, or surgical resection should be considered. | |||
</pre> | |||
===Micro=== | ===Micro=== |
edits